-
Featured
New Strategies for Heart Failure Patients Improves Outcomes
One-third of heart failure patients do not respond to cardiac resynchronization therapy (CRT) | A coordinated care approach at Mass General for heart failure patients improves outcomes.
-
Featured
The Promise of Ventricular-Assist Devices (VADs)
VAD technology is continually improving. Mass General data indicates new VADs improve 5-year survival rates. Trials for the latest generation are under way.
-
Protease inhibitors may increase risk of cardiovascular death in people with HIV and heart failure
A recent study led by Mass General researchers is the first to find that ritonavir-boosted protease inhibitor regimens increase the risk for heart failure events in persons with HIV.
-
Role of Genomics in Precision Medicine for Cardiovascular Disease
Christopher Newton-Cheh, MD, MPH, discusses how his team’s research contributes to a better understanding of how to treat patients with precision care by leveraging genetic information.
-
What Drives Heart Failure with Preserved Ejection Fraction
Jennifer Ho, MD, discusses her team’s recent work showing strong association between obesity and pulmonary hypertension, and their ongoing research to understand the mechanisms driving this association.
-
Macrophages Found to be Key Contributor to HFpEF
Macrophages expansion revealed to play a key role in HFpEF pathophysiology. Inhibiting IL-10 could be a potential therapy for the disease.
Learn more about Mass General's Heart Failure and Cardiac Transplant Program
Heart Failure contributors
-
James Louis Januzzi, MD
Hutter Family Professor of Medicine, Director, Dennis and Marilyn Barry Fellowship in Cardiology Research
Recent Article
Poster: A Clinical and Biomarker Scoring System to Predict the Presence of Obstructive PAD
-
Thoralf M. Sundt, MD
Chief, Division of Cardiac Surgery, Director, Corrigan Minehan Heart Center
Recent Article
ECMO Linked to Increased Survival Rate in High-Risk Pulmonary Embolism Patients
Cardiovascular Care at Mass General
At Mass General, our world-class physicians and nurses specialize in specific forms of both heart and vascular disease, and work closely together to offer leading treatments and preventive care for cardiovascular conditions.Resource links
